Combating Emerging and Re-emerging Infectious Diseases in Clinical Trials by Harnessing Innovative Technologies
About This EventThis webinar will highlight the challenges of emerging and re-emerging infectious diseases such as MTB, HIV, MRSA, and Ebola.
This presentation will also provide case studies on how innovative technologies like NGS are utilized to provide a deeper understanding of the pathogen and drug resistance pathways and thus provide better insights into developing diagnostics and therapies that are efficacious against the target pathogen and its resistant variants with improved safety.
Medical Laboratory Director and Scientific Advisor Tropical Diseases, Central Laboratories South Africa
Dr. Pany is the Sr. Medical Laboratory Director for the Q2 Solutions Laboratories located at Edinburgh, UK & Centurion, South Africa. He also serves as the Scientific Advisor for Microbiology/Tropical Diseases as part of the Medical and Scientific Affairs teams of Q2 Solutions. His primary responsibility include scientific and technical management of the laboratories and its employees. He also oversees developmental activities for TB and microbiology at Q2 Solutions. Dr. Pany started with Quintiles Clinical Trials Laboratory, Mumbai, in charge of the setting up and operation of bacteriology/molecular biology and mycobacteriology laboratories at Mumbai and Centurion facilities, respectively. Dr. Pany has an MD in microbiology from Bangalore Medical College and Research Institute and an MBBS from MKCG Medical College, Berhampur, Odisha. He holds a life membership of Indian Association of Medical Microbiologists (IAMM) and is also registered as a Professional Natural Scientist with the South African Council for Natural Scientific Professions (SACNASP). He has more than 17 years of experience in the medical field in various capacities – scientist, academician, clinician and surgeon with around 7 years within the clinical trial diagnostic industry. His areas of special interest are infectious diseases clinical trials especially tuberculosis, laboratory management, biosafety, assay development and diagnostics. He has experience as a Research Scientist and coordinator for R&D services at R&D Division (advanced genomics, proteomics and molecular biology), Super Religare Laboratories Ltd., Mumbai, and as Lecturer, Mycobacteriology Section, Department of Microbiology, St. John’s National Academy of Health Sciences, Bangalore. He has presented and published original research and reviews in reputed conferences and journals. Dr. Pany also served as a College of American Pathologists (CAP) Inspector in the fields of microbiology, immunology and molecular biology.
Senior Director/General Manager, Central Laboratories South Africa
Sorika van Niekerk is senior director of laboratory operations for Sub-Saharan Africa with a special interest and specific strategy to increase the infectious disease footprint for the laboratory. Sorika joined the clinical research industry in 1999 as a junior CRA. Throughout her years as a CRA, clinical team lead and clinical trial manager, she was involved in various studies including several Phase III flu vaccine trials, specifically focused on pediatrics and geriatrics. Her experience in monitoring Phase II and III trials covers a variety of therapeutic areas, including ophthalmology, infectious diseases as well as in the respiratory field. Sorika has held many leadership positions at Quintiles throughout her career including her role as executive director within Quintiles’ Clinical Operations organization, overseeing all clinical functions for Sub-Saharan Africa. Sorika has a Master of Science degree specializing in medical microbiology.